WINTON GROUP Ltd Takes Position in JAN $JAN

WINTON GROUP Ltd acquired a new position in shares of JAN (NYSE:JAN) in the 2nd quarter, HoldingsChannel.com reports. The fund acquired 103,859 shares of the company’s stock, valued at approximately $2,985,000.

Several other large investors have also recently added to or reduced their stakes in the business. Greenland Capital Management LP acquired a new position in JAN during the 2nd quarter worth $575,000. Readystate Asset Management LP bought a new position in JAN in the 2nd quarter valued at about $1,724,000. Wellington Management Group LLP acquired a new position in JAN during the 2nd quarter valued at about $8,739,000. Finally, Engineers Gate Manager LP acquired a new stake in shares of JAN in the 2nd quarter worth approximately $15,274,000. 6.27% of the stock is currently owned by institutional investors and hedge funds.

JAN Trading Up 0.3%

Shares of JAN stock opened at $30.91 on Friday. JAN has a 12-month low of $22.76 and a 12-month high of $32.83. The stock’s fifty day moving average is $30.38.

JAN (NYSE:JAN) last issued its quarterly earnings results on Tuesday, August 4th. The company reported $0.05 earnings per share for the quarter, missing analysts’ consensus estimates of $0.23 by ($0.18). The company had revenue of $216.46 million during the quarter, compared to analysts’ expectations of $203.32 million. The business’s revenue was up 45.4% on a year-over-year basis. JAN has set its FY 2026 guidance at 0.950-0.980 EPS. Equities research analysts predict that JAN will post 0.97 EPS for the current fiscal year.

JAN Dividend Announcement

The company also recently announced a monthly dividend, which will be paid on Wednesday, September 23rd. Stockholders of record on Friday, September 11th will be given a $0.0475 dividend. This represents a c) annualized dividend and a dividend yield of 1.8%. The ex-dividend date of this dividend is Friday, September 11th.

Wall Street Analysts Forecast Growth

A number of research analysts recently commented on the stock. Wall Street Zen upgraded shares of JAN from a “sell” rating to a “hold” rating in a research note on Saturday, August 8th. Royal Bank Of Canada increased their price target on JAN from $30.00 to $34.00 and gave the company an “outperform” rating in a research note on Monday, August 10th. Raymond James Financial began coverage on JAN in a research note on Tuesday, June 16th. They issued a “strong-buy” rating and a $34.00 price objective on the stock. Morgan Stanley upped their price objective on JAN from $28.00 to $31.00 and gave the company an “overweight” rating in a report on Tuesday, August 18th. Finally, Barclays lifted their target price on JAN from $33.00 to $34.00 and gave the stock an “overweight” rating in a report on Monday, August 31st. One investment analyst has rated the stock with a Strong Buy rating, eleven have assigned a Buy rating and three have assigned a Hold rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $31.71.

JAN News Summary

Here are the key news stories impacting JAN this week:

• Positive Sentiment: Huntington initiated coverage of JAN with an “Outperform” rating and a $36 price target, implying approximately 17% upside from the reported reference price of $30.76. The new bullish coverage may improve investor sentiment and broaden institutional awareness of the stock. Huntington initiates JAN coverage
• Positive Sentiment: The company’s latest reported quarter showed revenue of $216.5 million, up 45.4% year over year and above analyst expectations of $203.3 million. Management also provided fiscal 2026 EPS guidance of $0.95 to $0.98, broadly consistent with the analyst consensus of $0.97.
• Neutral Sentiment: JAN previously reported quarterly EPS of $0.05, below the $0.23 consensus estimate. The earnings miss remains a risk, although strong revenue growth and the reaffirmed full-year outlook may be cushioning its impact.
• Neutral Sentiment: Recent JAN-related articles about JAN-PRO cleaning standards and the consumer software application “Jan” do not appear to provide material new information about the publicly traded company and are unlikely to be significant stock catalysts.

JAN Company Profile

JanOne Inc is a technology and life sciences company focused on addressing the global opioid crisis. The company’s activities include developing and supporting pharmaceutical and other solutions intended to help reduce opioid-related deaths and dependency.

JanOne has also pursued blockchain and financial technology initiatives through its Alt 5 Sigma operations. These activities have included blockchain-based payment, digital asset and financial services solutions designed to help businesses manage transactions and related digital assets.

The company serves markets through its healthcare, technology and financial services initiatives, with an emphasis on solutions that can be applied internationally.